Speaker 1:

Prof. Charley WU

University of Surrey, UK

Profile:

Prof. Chuan-Yu (Charley) Wu is a professor of chemical engineering in the Department of Chemical and Process Engineering at the University of Surrey. UK. Prof. Wu has been the coordinator of two European Union (FP7 and H2020) consortia IPROCOM (2013-2016,€3.8m) and MATHEGRAM (2019-2023, €4.2m), which involve the development of computational tools for pharmaceuticals, and granular materials. Prof. Wu is an executive editor for Powder Technology, a leading peer reviewed journal on particle systems. He is also the Chief Editor for the “Materials Processing Engineering” subject of “Frontier in Chemical Engineering”. He co-authored a monograph on “Particle Technology and Engineering” published by Elsevier in 2016 and edited two books entitled “Discrete Element Modelling of Particulate Media” and “Particulate Materials: Synthesis, Characterisation, Processing and Modelling” published by RSC publishing. He also edited five journal special issues and published over 140 scientific papers. He has given more than 70 invited presentations and seminars at international conferences, industrial companies and universities worldwide. Prof. Wu is a member of the advisory and editorial board for “Particuology”, “Acta Pharmaceutica Sinica B (APSB) ” and “Journal of Engineering”.

Prof. Wu’s expertise lies in discrete element methods, finite element analysis, Machine learning, modelling and simulations, pharmaceutical engineering, particle technology and granular materials.  Prof. Wu has been working closely with global companies over the last 20 years in developing advanced numerical modelling techniques for manufacturing pharmaceuticals and fine chemicals. His research has been supported by global pharmaceutical companies including Pfizer, AstraZeneca, Genentech, Sanofi, Janssen, Alkermes and MSD, in addition to EPSRC and EU.

Speaker 2:

Dr. Yaning WANG

Createrna Science and Technology, China

Profile:

Dr. Yaning Wang is the CEO of Createrna Science and Technology. He was the Director of the Division of Pharmacometrics in the Office of Clinical Pharmacology at FDA until September 2021 and oversaw reviews, research projects, and policy development within the Division of Pharmacometrics for all disease areas. During his 18 years of service at FDA, Dr. Wang received numerous awards, including Award of Merit (highest award at FDA) and FDA Outstanding Service Award. Before joining FDA, Dr. Wang received his Ph.D. in Pharmaceutics and master’s degree in Statistics from the University of Florida in 2003. He also obtained a master’s degree in Biochemistry (1999) from National Doping Control Center and a bachelor’s degree in Pharmacy (1996) from Peking University in China. Dr. Wang served as a committee member for multiple Ph.D. candidates from various universities. He mentored more than 70 former research fellows (visiting scholars, post-doctoral scholars, and Ph.D. candidates) at FDA. Dr. Wang is a regulatory expert lecturer for three new drug development and regulatory courses (American Course on Drug Development and Regulatory Sciences, European Course in Pharmaceutical Medicine, Chinese Course on Drug Development and Regulatory Sciences). He served as a board member of the International Society of Pharmacometrics (ISoP) and is a fellow of ISoP. He is a member of the Advisory Committee for Chinese Pharmacometrics Society and a member of the Editorial Advisory Board for the Journal of Pharmacokinetics and Pharmacodynamics. Dr. Wang is an Adjunct Professor in the Department of Pharmaceutics at the University of Florida and Clinical Research Institute at Beijing University, and an invited lecturer in the College of Engineering and College of Pharmacy at the University of Michigan. Dr. Wang has published over 110 papers and given over 320 presentations at various national and international meetings as an expert in new drug development and regulation.

Speaker 3:

Dr Hongming CHEN

Guangzhou National Laboratory, China

Profile:

Dr Hongming Chen obtained his PhD in computational chemistry in 1998 from the Institute of Chemical Metallurgy, Chinese Academy of Sciences. After working as postdoctoral fellow in computational chemistry in Bayer Pharma Research Center in Wuppertal, Germany, he joined AstraZeneca R&D Gothenburg, Sweden, in 2001. He held a Principal Scientist position in Hit Discovery of Discovery Sciences, AstraZeneca. During 2019-2021, he worked at Bioland Laboratory (Guangzhou China) building the Molecular AI group and currently work as Principal Investigator at Guangzhou National Laboratory. He has been focusing in Cheminformatics, artificial intelligence/machine learning area and coauthored over 90 scientific publications/patents. He is currently a member of scientific advisory board of Molecular Informatics journal and editorial board of Artificial Intelligence in Life Science journal.

Speaker 4:

Prof. Dinggang SHEN

ShanghaiTech University, China

Profile:

Professor Dinggang Shen (IEEE Fellow, AIMBE Fellow, IAPR Fellow and MICCAI Fellow) is the Founding Dean of the School of Biomedical Engineering at ShanghaiTech University. Before joining ShanghaiTech, he was a tenured Professor of Radiology, Biomedical Research Imaging Center (BRIC), Computer Science, and Biomedical Engineering at the University of North Carolina at Chapel Hill (UNC), USA. He was also the Director of faculty development in the Department of Radiology, Director of Imaging Information Center, Director of IDEA lab, and Director of Image Analysis Core of BRIC at UNC. He is the Co-CEO of Shanghai United Imaging Intelligence Co., Ltd. He has published more than 1,590 papers, with an H-index of 128 and more than 70,000 citations. He serves in editorial boards of eight international journals, and also served as the General Chair of MICCAI 2019.

Professor Shen has been involved in the application of machine learning and artificial intelligence in medical image computing for a long time, including early brain development, early diagnosis, and the prediction of Alzheimer's disease, as well as diagnosis, prognosis and radiotherapy of brain tumor, breast cancer and prostate cancer. He is a pioneering scientist carrying out imaging AI research all over the world and is one of the first to apply deep learning to medical imaging (2012).

Speaker 5:

Prof. Wei ZHAO

Shandong University, China

Profile:

Wei Zhao, Pharm.D., Ph.D., Professor of clinical pharmacist and pharmacologist currently working as the chair of department of clinical pharmacy and director of institute of clinical pharmacology at Shandong University, deputy director of NMPA key laboratory for clinical research and evaluation of innovative drug at Qilu Hospital and directors of clinical trial centers at Shandong Provincial Qianfoshan Hospital and the Second Hospital of Shandong University, China. He leads a research group focused on clinical trial and personalized therapy.

Prof Zhao also works as a regulator scientist. He was nominated as a member and expert of the pediatric committee in the French National Agency of Medicine and Health Products Safety in 2015 and a member and expert of modeling & simulation working party and extrapolation working group in European Medicines Agency. He collaborates with the Chinese Center for Drug Evaluation to develop the national guidelines for drug development.

Speaker 6:

Prof. Jianfeng PEI

Peking University, China

Profile:

Prof. Pei is full professor at the Center for Theoretical Biology, Academy for Advanced Interdisciplinary Studies, Peking University. Dr. Pei obtained his B.S. degree from Wuhan University in 1995 and Ph.D. degree from the Institute of Process Engeering, the Chinese Academy of Sciences in 2002. Then he worked as a postdoctoral fellow in Peking university and SUNY Buffalo. In 2007, he joined the Academy for Advanced Interdisciplinary Studies, Peking University. His research focused on structure-based drug design and drug discovery using artificial intellectual techniques.  

Speaker 7:

Prof. Zenghui ZHANG

Shenzhen Institute of Advanced Technology, Shenzhen, China

Profile:

John Z.H. Zhang is a chair professor in Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences.

Professor Zhang received his Ph.D. in Chemical Physics from University of Houston, USA in 1987. He then worked as a postdoctoral fellow and assistant researcher in the Department of Chemistry at the University of California, Berkeley. He was an assistant professor, associate professor, and professor in the Department of Chemistry at New York University. He was the Director of the Institute of Theoretical and Computational Chemistry of the Special Economic Zone of Nanjing University, Professor of East China Normal University, Director of NYU-ECNU Center for Computational Chemistry at NYU Shanghai. Professor Zhang has been awarded the Camille and Henry Dreyfus New Faculty Award, Alfred P. Sloan Research Fellow, Camille Dreyfus Teacher-Scholar, and National Science Foundation Presidential Faculty Fellow and the Fellow of the Royal Society of Chemistry (UK). So far, he has published more than 400 papers in academic journals, with more than 12,000 citations and an H-index index of 58 (web of science).  He is currently an Associate Editor of Phys. Chem. Chem. Phys. and serves on the editorial boards of several international journals.

Speaker 8:

Prof. Zhong ZUO

Chinese University of Hong Kong, Hongkong, China

Profile:

Professor Joan Zuo is the Director and Professor of the School of Pharmacy at the Chinese University of Hong Kong. She holds a B. Sc. and a Ph.D. in Pharmaceutical Sciences and has had over 25 years’ experience in the biopharmaceutics and pharmacokinetics fields. Since she joined the School of Pharmacy at the Chinese University of Hong Kong in Jan 2000, Prof. Zuo has secured over 24 million continuous supports from various grant agencies such as University Grant Council, Innovation Technology Foundation, Food and Health Bureau, Hospital Authority in Hong Kong SAR as PI to support her series investigations on biopharmaceutics and pharmacokinetics of both western drug molecule and herbal bioactive components. Her research achievements have been applied to areas such as improvement of quality control and delivery of western drugs as well as herbal products, elucidation or even prediction of potential herb/drug interactions in vivo. Prof. Zuo’s research findings in the above fields have generated over 300 original research and conference papers and patents of USA, China, Hong Kong and Malaysia.

In Hong Kong, Prof. Zuo is serving in the Pharmacy & Poison’s Board, Pharmacy Internship Training Committee, Pharmacovigilance Committee, TCM Research and Development Committee and Proprietary Traditional Chinese Medicine Registration Committee at the government of Hong Kong Special Administration Region, China. She is currently the Council member of the Metropolitan University of Hong Kong and Incu-Bio and Expert Panels of the Hong Kong Science & Technology Parks Corporation.

Internationally, Prof. Zuo is the Fellow of American Association of Pharmaceutical Scientists and has served as nomination committee member for International Society of Xenobiotics (ISSX). Currently, she is the regional editor of European Journal of Pharmaceutical Sciences and editorial board member for Biopharmaceutics and Drug Dispositions, Xenobiotica, Chinese Medicine and, grant reviewer for China and Macau, and journal reviewer for more than 50 international peer reviewed journals.

Speaker 9:

Prof. Buyong MA

Shanghai Jiaotong University, China

Profile:

Buyong Ma is a Professor in the School of Pharmacy, Shanghai Jiaotong University. He obtained his Ph.D. at the University of Georgia under Professor H. F. Schaefer. From 1995 to 1998, he was a postdoc with Professor N. L. Allinger, focusing on the development and application of molecular mechanics. In 1998, he joined the NCI-NIH and started his research in computational biology. After brief one-year work at Locus Pharmaceuticals, he accepted a Senior Scientist position in Leidos Biomedical Research Inc, National Cancer Institute of NIH in 2003. He has authored over 200 scientific papers. His current research activities are in the fields of computational immunology and antibody design related to cancer and protein aggregation diseases, as well as in the development and application of AI in pharmacy

Speaker 10:

Dr. Zheng WANG

Wuxi AppTec, China

Profile:

Dr. Zheng Wang is a Senior Director at WuXi AppTec New Drug Development Ltd., a global company with operations across Asia, Europe, and North America. WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients.

Dr. Wang’s research interest is in the application of AI technology in chemical inverse synthesis.

Speaker 11:

Prof. Xiaochuan CAI

Associate Dean (Research and Graduate Studies), Faculty of Science and Technology, University of Macau

Profile:

Dr. Cai is the UMDF Chair Professor of Applied Mathematics, Associate Dean (Research and Graduate Studies), and Director of Centre for Applied Mathematics atFaculty of Science and Technology, University of Macau.

Dr. Cai received his BSc degree in 1984 from Peking University, his MSc in 1988 and PhD in 1989 from Courant Institute, New York University.

Dr. Cai’s research interests are in the general area of scientific and engineering computing including parallel algorithms and high-performance software for linear and nonlinear partial differential equations, domain decomposition methods, multigrid methods, numerical linear algebra, PDE constrained optimizations, inverse problems, stochastic partial differential equations, computational fluid dynamics, fluid-structure interactions, computational biomechanics, and parallel processing.

Speaker 12:

Prof.YuTao XIANG

Professor, Faculty of Health Sciences, University of Macau

Profile:

Yu-Tao XIANG, MD, PhD, is Professor in Faculty of Health Sciences at University of Macau. Dr. Xiang completed resident psychiatrist training in Beijing Anding Hospital, China, obtained PhD degree in Chinese University of Hong Kong Department of Psychiatry, and received Postdoctoral Fellow training in University of Maryland Department of Psychiatry, USA. His research focuses on psychiatric epidemiology, evidence-based medicine, health service research, and COVID-19 related research.

Speaker 13:

Prof.Yuanjia HU

Professor, Institute of Chinese Medical Sciences, University of Macau

Profile:

Dr. Yuanjia Hu is Professor, Programme Coordinator of Medicinal Administration in Institute of Chinese Medical Sciences, University of Macau, and Deputy Director of the Systematic Research Center of the State Key Laboratory of Quality Research of Chinese Medicine. Dr. Yuanjia Hu received B.Sc. degree of pharmacy administration from China Pharmaceutical University, Ph.D. degree in Biomedical Sciences from the University of Macau, and Guest Researcher fellowship in Austrian Institute of Technology.

Dr. Hu focused on pharmaceutical intellectual property and complex system analysis and firstly established valuation model specific to pharmaceutical patents. He led over 20 research projects financed by The National Natural Science Foundation of China, The National Social Science Fund of China, The Science and Technology Development Fund of Macao SAR, and Austrian Science Fund etc, supervised over 30 Ph.D. and master students and postdoctoral researchers, published over 100 SCI/SSCI papers, and delivered over 100 speeches worldwide. He is also Deputy Secretary-General and Executive Council Member in Specialty Committee on Network Pharmacology of World Federation of Chinese Medicine Societies, Project Researcher in the Research Center of National Drug Policy & Ecosystem, Policy Expert in Financial Innovation Pilot Platform of State Intellectual Property Operation Public Service Platform, an Arbitrator in Zhuhai Arbitration Commission, and Patent Reviewer in the University of Macau.

Speaker 14:

Prof. Defang OUYANG

Associate Professor, Institute of Chinese Medical Sciences, University of Macau

Profile:

Dr. Ouyang has a multidisciplinary background in pharmaceutics & computer modelling, with experience in academia and industry. He obtained his bachelor (2000) and master (2005) in pharmaceutics from Shenyang Pharmaceutical University, China. He completed his PhD in pharmacy at The University of Queensland, Australia, in 2010 and progressed directly to his faculty position (Lecturer in Pharmaceutics, PI) at Aston University (UK). From the end of 2014, he moved to the University of Macau.

Since 2011, he has pioneered the integration of multi-scale modeling, artificial intelligence, and big data techniques in the field of drug delivery – “computational pharmaceutics”. He has published 2 books, 5 book chapters and over 100 refereed SCI journal papers. He held 11 patents, which had been used in medicinal products. He edited the first book “Computational Pharmaceutics – the application of molecular modeling in drug delivery” (John Wiley & Sons Inc., 2015) in this research area. He is invited to be associate editor of “Drug Delivery and Translational Research” and editorial board of multiple pharmaceutical journals. He established the first global artificial intelligence (AI)-based formulation platform “FormulationAI”.